BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 33567811)

  • 41. A new mode for the diagnosis of angioimmunoblastic T-cell lymphoma.
    Wang H; Han X; Nie Y; Zhang C; Li J; Yang R; Jiang Y
    Cell Mol Biol (Noisy-le-grand); 2024 May; 70(5):155-160. PubMed ID: 38814221
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Distinguishing angioimmunoblastic T-cell lymphoma from peripheral T-cell lymphoma, unspecified, using morphology, immunophenotype and molecular genetics.
    Attygalle AD; Chuang SS; Diss TC; Du MQ; Isaacson PG; Dogan A
    Histopathology; 2007 Mar; 50(4):498-508. PubMed ID: 17448026
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Molecular mechanisms of angioimmunoblastic T-cell lymphoma].
    Sakata-Yanagimoto M
    Rinsho Ketsueki; 2015 Mar; 56(3):246-52. PubMed ID: 25876776
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Angioimmunoblastic T-cell lymphoma in Taiwan shows a frequent gain of ITK gene.
    Liang PI; Chang ST; Lin MY; Hsieh YC; Chu PY; Chen CJ; Lin KJ; Jung YC; Hwang WS; Huang WT; Chang WC; Ye H; Chuang SS
    Int J Clin Exp Pathol; 2014; 7(9):6097-107. PubMed ID: 25337257
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Angioimmunoblastic T-cell lymphoma in Taiwan reveals worse progression-free survival for
    Hsu YT; Wang YC; Chen RY; Hung LY; Li SS; Yen CC; Chen TY; Medeiros LJ; Chang KC
    Leuk Lymphoma; 2020 May; 61(5):1108-1118. PubMed ID: 31870198
    [TBL] [Abstract][Full Text] [Related]  

  • 46. RhoA G17V is sufficient to induce autoimmunity and promotes T-cell lymphomagenesis in mice.
    Ng SY; Brown L; Stevenson K; deSouza T; Aster JC; Louissaint A; Weinstock DM
    Blood; 2018 Aug; 132(9):935-947. PubMed ID: 29769264
    [TBL] [Abstract][Full Text] [Related]  

  • 47. TET-2 mutations predict poor outcomes and are associated with unfavorable clinical-biological features in PTCL, not otherwise specified and angioimmunoblastic T-cell lymphoma in Brazilian patients.
    de Pádua Covas Lage LA; Barreto GC; Culler HF; Cavalcante JB; de Oliveira Alves LB; Nardinelli L; Bendit I; Zerbini MCN; Rocha V; Pereira J
    Cancer Biomark; 2022; 35(2):179-191. PubMed ID: 36093687
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Peripheral T-cell lymphoma with a T follicular-helper phenotype: A different entity? Results of the Spanish Real-T study.
    Martín García-Sancho A; Rodríguez-Pinilla SM; Domingo-Domenech E; Climent F; Sánchez-Garcia J; López Jiménez J; García-Cosío Piqueras M; Castellvi J; González AJ; González de Villambrosia S; Gómez Codina J; Navarro B; Rodríguez G; Borrero JJ; Fraga M; Naves A; Baeza L; Córdoba R
    Br J Haematol; 2023 Oct; 203(2):182-193. PubMed ID: 37386897
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinicopathological features of programmed cell death-1 and programmed cell death-ligand-1 expression in the tumor cells and tumor microenvironment of angioimmunoblastic T cell lymphoma and peripheral T cell lymphoma not otherwise specified.
    Kim S; Kwon D; Koh J; Nam SJ; Kim YA; Kim TM; Kim CW; Jeon YK
    Virchows Arch; 2020 Jul; 477(1):131-142. PubMed ID: 32170448
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinicopathological Study of 30 Cases of Peripheral T-cell Lymphoma with Hodgkin and Reed-Sternberg-like B-cells from Japan.
    Eladl AE; Satou A; Elsayed AA; Suzuki Y; Kato S; Asano N; Nakamura S
    Am J Surg Pathol; 2017 Apr; 41(4):506-516. PubMed ID: 28125450
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Management of Angioimmunoblastic T-Cell Lymphoma (AITL) and other T Follicular Helper Cell lymphomas (TFH PTCL).
    Ma H; O'Connor OA; Marchi E
    Semin Hematol; 2021 Apr; 58(2):95-102. PubMed ID: 33906727
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Follicular variant of peripheral T-cell lymphoma: a clinicopathologic and genetic study of 2 cases].
    Zhan HQ; Zhu XZ; Li XQ; Zhou XY
    Zhonghua Bing Li Xue Za Zhi; 2011 Jan; 40(1):32-6. PubMed ID: 21429356
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Peripheral T-cell lymphoma: molecular profiling recognizes subclasses and identifies prognostic markers.
    Rodríguez M; Alonso-Alonso R; Tomás-Roca L; Rodríguez-Pinilla SM; Manso-Alonso R; Cereceda L; Borregón J; Villaescusa T; Córdoba R; Sánchez-Beato M; Fernández-Miranda I; Betancor I; Bárcena C; García JF; Mollejo M; García-Cosio M; Martin-Acosta P; Climent F; Caballero D; de la Fuente L; Mínguez P; Kessler L; Scholz C; Gualberto A; Mondéjar R; Piris MA
    Blood Adv; 2021 Dec; 5(24):5588-5598. PubMed ID: 34592752
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The new biology of PTCL-NOS and AITL: current status and future clinical impact.
    Timmins MA; Wagner SD; Ahearne MJ
    Br J Haematol; 2020 Apr; 189(1):54-66. PubMed ID: 32064593
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Abnormal immunophenotype of the T-cell-receptor beta Chain in follicular-helper T cells of angioimmunoblastic T-cell lymphoma.
    Mao ZJ; Surowiecka M; Linden MA; Singleton TP
    Cytometry B Clin Cytom; 2015; 88(3):190-3. PubMed ID: 25619965
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clonal haematopoiesis: A common progenitor for cytotoxic peripheral T-cell lymphoma and angioimmunoblastic T-cell lymphoma.
    Vogelsberg A; Harland L; Borgmann V; Otto F; Weller JF; Nann D; Quintanilla-Martinez L; Fend F
    Br J Haematol; 2024 May; 204(5):2071-2076. PubMed ID: 38323682
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Large cell morphology, CMYC+ tumour cells, and PD-1+ tumour cell/intense PD-L1+ cell reactions are important prognostic factors in nodal peripheral T-cell lymphomas with T follicular helper markers.
    Mihashi Y; Kimura S; Iwasaki H; Oshiro Y; Takamatsu Y; Kawauchi S; Shimajiri S; Ishizuka K; Takeshita M
    Diagn Pathol; 2021 Nov; 16(1):101. PubMed ID: 34742294
    [TBL] [Abstract][Full Text] [Related]  

  • 58. G17V RHOA: Genetic evidence of GTP-unbound RHOA playing a role in tumorigenesis in T cells.
    Chiba S; Enami T; Ogawa S; Sakata-Yanagimoto M
    Small GTPases; 2015; 6(2):100-3. PubMed ID: 26103434
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Inhibition of choline metabolism in an angioimmunoblastic T-cell lymphoma preclinical model reveals a new metabolic vulnerability as possible target for treatment.
    Krug A; Tosolini M; Madji Hounoum B; Fournié JJ; Geiger R; Pecoraro M; Emond P; Gaulard P; Lemonnier F; Ricci JE; Verhoeyen E
    J Exp Clin Cancer Res; 2024 Feb; 43(1):43. PubMed ID: 38321568
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Flow Cytometry Analysis Reveals a Wide Cytologic and Immunophenotypic Spectrum of Peripheral B Lymphocytes in Angioimmunoblastic T-Cell Lymphoma.
    Liu HL; Liao CK; Weng SW; Shih LY; Chou CC; You HL; Wang MC; Huang WT
    Pathobiology; 2023; 90(3):187-198. PubMed ID: 36423589
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.